Stocks / Pharmaceuticals

OCULPharmaceuticals

Ocular Therapeutix, Inc.
$9.801d -2.7%5d -14.0%settled close · 2026-09-16
Mkt cap $1.8B (3/25)β 1.0252w $7.96–11.77Shares 217.7MInd. Pharmaceutical PreparationsNasdaq since 2014Emp. 325HQ Bedford, MAocutx.com
Who’s talkingIdea Scout · free

Who’s talking about OCUL

No tracked investor commentary on OCUL yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 2 Nov 2026 after the close

Confirmed date · consensus EPS -0.37. Reactions below are the next settled session over the prior close.
The options tape

Notable options days

Sessions in the last 120 where OCUL’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 11 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-16
2026-08-19
2026-08-17
2026-08-12
2026-07-15
2026-07-14
2026-07-13
2026-07-10
2026-07-06
2026-06-11
2026-06-10
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on OCUL is in this morning’s Brief. Get The Brief — $20/mo →